Boyce Sarah 4
4 · Avidity Biosciences, Inc. · Filed Dec 19, 2025
Insider Transaction Report
Form 4
Boyce Sarah
DirectorPresident and CEO
Transactions
- Award
Common Stock
2025-12-17+31,000→ 336,871 total - Tax Payment
Common Stock
2025-12-17$71.87/sh−15,742$1,131,378→ 321,129 total - Gift
Common Stock
2025-12-18−29,159→ 291,970 total
Footnotes (3)
- [F1]Represents shares acquired upon the vesting of performance-based restricted stock units (PSUs). Each PSU represented a contingent right to receive one share of the Issuer's common stock. The PSUs were originally granted to the Reporting Person on October 30, 2024. The PSUs were accelerated and settled on December 17, 2025 for tax planning purposes and such shares remain subject to recoupment by the Issuer if the Reporting Person's employment is terminated by the Issuer for cause or by the Reporting Person without good reason.
- [F2]Represents the number of shares withheld by the Issuer to cover tax withholding in connection with the settlement of PSUs on December 17, 2025.
- [F3]Represents a gift of shares to a Donor Advised Fund.